OK Biotech Co., Ltd. Stock Price

TWSE:4155 Community·NT$1.9b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

4155 Share Price Performance

NT$13.35

-3.75 (-21.93%)

NT$13.35

-3.75 (-21.93%)

NT$13.35

Fri, 3 Apr 26

Share Pricen/a

4155 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Excellent balance sheet second-rate dividend payer.

3 Risks

0 Rewards

View Full Analysis

OK Biotech Co., Ltd. Key Details

Last Reported Earnings

Dec 31, 2025

Next Reporting Earnings

n/a

: 0.58
: 27.58%
: 5.30%
: 35.4%

View Full Analysis

About 4155

Founded: 2004
Employees: n/a
CEO: Chia-De Lai
WebsiteView website: www.okbiotech.com

OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-frequency therapy devices, and factory setup solutions, as well as professional OEM/ODM customized services. The company sells its products under the OKB and Prodigy brands. OK Biotech Co., Ltd. was incorporated in 2004 and is headquartered in Hsinchu City, Taiwan.